May 5, 2021 Vaccibody AS appoints Dr. Volck, M.D., Ph.D. as new member of the Board
Posted at 16:18h
in Uncategorized
View press release (PDF)...
May 5, 2021 MINUTES OF ANNUAL GENERAL MEETING IN VACCIBODY AS
Posted at 14:39h
in Uncategorized
View press release (PDF) MINUTES OF ANNUAL GENERAL MEETING IN VACCIBODY AS (PDF)...
April 30, 2021 Status update on VB C-02 clinical trial with VB10.16 and immune checkpoint inhibitor atezolizumab
Posted at 08:26h
in Uncategorized
Status update on VB C-02 clinical trial...
April 28, 2021 Vaccibody appoints Harald Gurvin as new Chief Financial Officer
Posted at 08:08h
in Uncategorized
Vaccibody appoints Harald Gurvin as new Chief Financial Officer View press release (PDF)...
April 28, 2021 Notice of Annual General Meeting on May 5, 2021
Posted at 08:02h
in Uncategorized
Notice of AGM on May 5, 2021 View press release (PDF)...
April 21, 2021 Vaccibody 2020 Annual Report
Posted at 08:02h
in Uncategorized
Vaccibody 2020 Annual Report View press release (PDF) Annual Report 2020 (PDF)...
April 20, 2021 Unaudited Restated 2019 figures
Posted at 20:45h
in Uncategorized
Unaudited Restated 2019 figures. View press release (PDF)...
March 5, 2021 Vaccibody to adopt IFRS (International Financial Reporting Standards) and to explore a potential listing of its shares on the Nasdaq Global Market in the United States
Posted at 08:05h
in Uncategorized
Vaccibody to adopt IFRS and to explore a potential listing of its shares on the Nasdaq Global Market...
February 5, 2021 Vaccibody will recruit new CFO
Posted at 19:27h
in Uncategorized
Vaccibody AS, a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel vaccine and immunotherapies, announced today that its CFO, Lars Dencker Nielsen, is stepping down and will leave the Company at the end of the month. Vaccibody has retained a leading global executive...
December 10, 2020 Vaccibody reports promising preclinical data with a second-generation COVID-19 vaccine and announces its infectious disease strategy
Posted at 10:26h
in Uncategorized
Vaccibody reports promising preclinical data with a second-generation COVID-19 vaccine and announces its infectious disease strategy. View press release (PDF)...